USP7 and breast carcinoma: The USP7-specific FT671 inhibitor (IC50 = 52 nM) is active against CRC and breast cancer, blocking the proliferation of MM.1S cells with an IC50 value of 0.33 μM, as determined by the CellTiter-Glo assay.